Document:

EXHIBIT 10.1

IVOW MERGER VOTING AGREEMENT

This IVOW MERGER  VOTING AGREEMENT (this “Agreement”)
is made and entered into as of September 20, 2006 (the “Effective
Date”), by and among iVOW, Inc., a Delaware corporation (“iVOW”), and MedCap Partners L.P. and MedCap Master Fund L.P. (collectively, “Shareholder”).

RECITALS

A.            This Agreement is entered into in connection with that
certain Agreement and Plan of Reorganization (the “Merger Agreement”) dated as
of September 20, 2006, by and among iVOW, Crdentia Corp., a Delaware
corporation (“Crdentia”), and iVOW
Acquisition Corp. a Delaware corporation and wholly-owned subsidiary of
Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW
continuing as the surviving corporation of the merger and becoming a
wholly-owned subsidiary of Crdentia (the “Merger”).  Capitalized terms used in this Agreement
which are not otherwise defined herein will have the meanings given to such
terms in the Merger Agreement.

B.            As of the Effective Date of this Agreement, Shareholder
owns in the aggregate (including shares held both beneficially and of record
and other shares held either beneficially or of record) the number of shares of
iVOW Common Stock set forth below Shareholder’s name on the signature page of
this Agreement (all such shares together with any shares of voting stock of
iVOW that may hereafter be acquired by Shareholder, being collectively referred
to herein as the “Subject Shares”).

C.            Shareholder is entering into this Agreement as a material
inducement to, and in consideration of, Crdentia’s willingness to enter into
the Merger Agreement.

AGREEMENT

The parties to this
Agreement, intending to be legally bound, agree as follows:

1.             Transfer of Subject Shares.

1.1          No Disposition or Encumbrance of
Subject Shares. 
Shareholder agrees that, prior to the Expiration Date, Shareholder will
not, directly or indirectly, sell, transfer, exchange, pledge or otherwise
dispose of, or in any other way reduce Shareholder’s risk of ownership or
investment in, or make any offer or agreement relating to any of the foregoing
with respect to, any Subject Shares, except pursuant to the Merger Agreement
and except for distributions of shares to Shareholder’s limited partners, or
sales of shares with the proceeds distributed to Shareholder’s limited
partners, in the ordinary course of Shareholder’s business consistent with the
terms of the Shareholder’s Limited Partnership Agreement made in order to
satisfy Shareholder’s obligations to its limited partners upon the redemption
of fund interests in accordance with Shareholder’s Limited Partnership
Agreement.  As used herein, the term

 

“Expiration Date”
means the earliest to occur of (i) the Effective Time of the Merger, or (ii)
such time as the Merger Agreement or this Agreement may be terminated in
accordance with their respective terms.

1.2          Transfer of Voting Rights.  Shareholder agrees that,
prior to the Expiration Date, Shareholder will not deposit any of the Subject
Shares into a voting trust or grant a proxy or enter into an agreement of any
kind with respect to the voting of any of the Subject Shares, except for the
Proxy called for by Section 2.2 of this Agreement.

2.             Voting
of Subject Shares.

2.1          Voting Agreement.  Shareholder agrees that,
prior to the Expiration Date, at any meeting of the shareholders of iVOW,
however called, and in any action taken by the written consent of shareholders
of iVOW without a meeting to vote as set forth therein, Shareholder will vote
the Subject Shares:

(i)            in favor of the Merger, the
execution and delivery by iVOW of the Merger Agreement and the adoption and
approval of the terms thereof and in favor of each of the other actions and
transactions contemplated by the Merger Agreement and any action required in
furtherance hereof and thereof;

(ii)           against any action or agreement that
would result in a breach of any representation, warranty, covenant or
obligation of iVOW in the Merger Agreement or that would preclude fulfillment
of a condition precedent under the Merger Agreement to iVOW’s obligations to
consummate the Merger; and

(iii)          against the following actions (other
than the Merger and the transactions contemplated by the Merger
Agreement):  (A) the sale or exchange of
iVOW’s capital stock, other than (x) upon exercise or conversion of iVOW’s
outstanding options, warrants or notes, or (y) to any employee, consultant or
director of iVOW for purposes of retaining their services, (B) the merger of
iVOW with, or the direct or indirect disposition of a significant amount of the
assets or the business of iVOW to, any third party, or (C) the licensing of
iVOW IP Rights to any third party other than licensing transactions which are
in the ordinary course of iVOW’s business and not material to iVOW or its
business (each of the actions described in clauses (A), (B) and (C) being
referred to herein as an “Alternative Transaction”);
(D) any reorganization, recapitalization, dissolution or liquidation of iVOW or
any subsidiary of iVOW; (E) any material change in the capitalization of iVOW
or iVOW’s corporate structure not contemplated by the Merger Agreement; or (F)
any other action which is intended, or could reasonably be expected to, impede,
interfere with, delay, postpone, discourage or adversely affect the Merger or
any of the other transactions contemplated by the Merger Agreement or this
Agreement.

Prior to the Expiration
Date, Shareholder will not enter into any agreement or understanding with any
person or entity to vote or give instructions in any manner inconsistent with
this Section 2.1.

 2
 

 

2.2          Proxy.  Contemporaneously with the
execution of this Agreement, Shareholder will deliver to iVOW a proxy with
respect to the Subject Shares in the form attached hereto as Exhibit 1,
which proxy will be irrevocable to the fullest extent permitted by law (the “Proxy”) and will provide that iVOW
may vote the Subject Shares in accordance with Section 2.1.

 3
 

 

3.             No
Solicitation.  From
the date hereof until the Expiration Date, Shareholder will not, and will not
authorize or permit any agent or representative of Shareholder to, directly or
indirectly:  (i) solicit, initiate or
induce the making, submission or announcement of any Company Acquisition
Proposal (as that term is defined in the Merger Agreement), (ii) participate in
any discussions or negotiations regarding, or furnish to any person any
non-public information with respect to, or take any other action to facilitate
any inquiries or the making of any proposal that constitutes or may reasonably
be expected to lead to, any Company Acquisition Proposal, (iii) engage in
discussions with any person with respect to any Company Acquisition Proposal,
except as to disclose the existence of these provisions, (iv) endorse or
recommend any Company Acquisition Proposal, or (v) enter into any letter of
intent or similar document or any contract, agreement or commitment
contemplating or otherwise relating to any Company Acquisition Proposal.  If Shareholder becomes aware of any such
offer, or any discussions, negotiations, inquiries, proposals or contacts with
respect to any Company Acquisition Proposal, Shareholder agrees to advise iVOW
in writing of any Company Acquisition Proposal or of any request for nonpublic
information or other inquiry which the party reasonably believes could lead to
a Company Acquisition Proposal, the material terms and conditions of such
Company Acquisition Proposal (to the extent known), and the identity of the
person or group making any such request, inquiry or Company Acquisition
Proposal.

4.             Representations, Warranties and
Covenants of Shareholder. 
Shareholder hereby represents, warrants and covenants as follows:

4.1          Authority, Enforceability.  Shareholder has the
capacity and the full power and authority to enter into, execute, deliver and
perform Shareholder’s obligations under this Agreement and to make the
representations, warranties and covenants contained herein, and that all
corporate or similar action required for the authorization, execution, delivery
and the performance of all obligations of Shareholder under this Agreement and
the agreements contemplated hereby have been obtained.  This Agreement has been duly executed and
delivered by Shareholder and constitutes a legal, valid and binding obligation
of Shareholder, enforceable against Shareholder in accordance with its terms.

4.2          Shares Owned.  As of the Effective Date of this Agreement,
Shareholder owns in the aggregate (including shares held both beneficially and
of record and other shares held either beneficially or of record) the number of
shares of iVOW Common Stock and other securities of iVOW set forth below
Shareholder’s name on the signature page of this Agreement, and does not
directly or indirectly own, either beneficially or of record, any shares of
capital stock of iVOW, or rights to acquire any shares of capital stock of
iVOW, or other securities of iVOW, other than the securities set forth below
Shareholder’s name on the signature page hereof.

4.3          Further Assurances.  Shareholder agrees to execute and deliver any
additional documents reasonably necessary or desirable, in the opinion of iVOW,
to carry out the purposes and intent of this Agreement and the Proxy.

 4
 

 

5.             Miscellaneous.

5.1          Severability.  If any provision of this
Agreement, or the application thereof, will for any reason and to any extent be
invalid or unenforceable, the remainder of this Agreement and application of
such provision to other persons or circumstances will be interpreted so as to
reasonably effect the intent of the parties hereto.

5.2          Amendment and Waiver.  This Agreement or any provision hereof may be
amended, modified, superseded, canceled, renewed, waived or extended only by an
agreement in writing executed by iVOW and Shareholder.  The waiver by a party of any breach hereof or
default in the performance hereof will not be deemed to constitute a waiver of
any other default or any succeeding breach or default.

5.3          Assignment.  This Agreement and all rights and obligations
hereunder are personal to Shareholder and may not be transferred or assigned by
Shareholder at any time.  iVOW may assign
its rights, together with its obligations hereunder, to any parent, subsidiary,
affiliate or successor of iVOW, as the case may be.  This Agreement will be binding upon, and
inure to the benefit of, the persons or entities who are permitted, by the
terms of this Agreement, to be successors, assigns and personal representatives
of the respective parties hereto.

5.4          Governing Law.  The validity, interpretation and enforcement
of this Agreement will be governed by and construed in accordance with the
internal laws of the State of Delaware, excluding that body of laws pertaining
to conflict of laws.

5.5          Costs of Enforcement.  If any party to this Agreement seeks to
enforce its rights under this Agreement by legal proceedings or otherwise, the
non-prevailing party will pay all costs and expenses incurred by the prevailing
party, including, without limitation, all reasonable attorneys’ and experts’
fees.

5.6          Counterparts.  This Agreement may be executed in
counterparts, each of which will be deemed an original but all of which, taken
together, constitute one and the same agreement.

5.7          Entire Agreement.  This Agreement and the documents referred to
herein constitute the entire agreement and understanding of the parties with
respect to the subject matter of this Agreement, and supersede all prior
understandings and agreements, whether oral or written, between or among the
parties hereto with respect to the specific subject matter hereof.

5.8          Specific Performance; Injunctive
Relief.  The
parties hereto acknowledge that iVOW will be irreparably harmed and that there
will be no adequate remedy at law for a violation of any of the covenants or
agreements of Shareholder set forth herein. 
Therefore, it is agreed that, in addition to any other remedies that may
be available to iVOW upon any such violation, iVOW shall have the right to
enforce such covenants and agreements by specific performance, injunctive
relief or by any other means available to iVOW at law or in equity.

 5
 

 

5.9          Notices.  All notices and other communications required
or permitted under this Agreement shall be in writing and shall be either hand
delivered in person, sent by facsimile (with confirmation of receipt), sent by
certified or registered first class mail, postage pre-paid, or sent by
nationally recognized express courier service. 
Such notices and other communications will be effective upon receipt if
hand delivered or sent by facsimile (provided the sender receives confirmation
of receipt), three (3) business days after mailing if sent by mail, and one (1)
business day after dispatch if sent by express courier, to the following
addresses:

If to iVOW:

iVOW,
Inc.

11455
El Camino Real, Suite 140

San
Diego, CA  92130

Attention:  Chief Executive Officer

Facsimile No.: (858) 847-4811

with a copy to:

Heller Ehrman LLP

4350 La Jolla Village Drive, 7th Floor

San Diego, CA  92122

Attention: Michael S. Kagnoff

Facsimile No.: (858) 450-8499

If to Shareholder:

To the address for Shareholder set forth on the signature page hereof;

or to such other
address as a party may have furnished to the other parties in writing pursuant
to this Section 5.9.

[Remainder of Page Intentionally Left Blank]

 6

 

IN WITNESS WHEREOF, the
undersigned parties have executed this Agreement as of the date first above
written.

 

iVOW, Inc.

	
  By:

  	
   

  	
   

  
	
   

  
	
  Name:

  	
   

  	
   

  
	
   

  
	
  Title:

  	
   

  	
   

  
	
   

  
	
   

  
	
  SHAREHOLDER

  
	
   

  
	
  MEDCAP
  PARTNERS L.P.

  
	
   

  
	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  
						

 

iVOW Common Stock:        shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase      
shares of Common Stock

	
  Address:

  
	
   

  
	
  MEDCAP
  MASTER FUND L.P.

  
	
   

  
	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

iVOW Common Stock:        shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase       
shares of Common Stock

Address:

 

 

[Signature Page to iVOW Merger Voting Agreement]

 

EXHIBIT 1
TO IVOW MERGER VOTING AGREEMENT

IRREVOCABLE PROXY

The undersigned
shareholders of iVOW, Inc., a Delaware corporation (“iVOW”),
hereby irrevocably (to the fullest extent permitted by law) appoint and
constitute John Lyon or Richard Gomberg of iVOW, and each of them, the attorneys
and proxies of the undersigned, with full power of substitution and
resubstitution, to the extent described below and, with respect to such
matters, to the fullest extent of the undersigned’s rights with respect to
(i) the shares of capital stock of iVOW owned by the undersigned as of the
date of this proxy, which shares are specified on the final page of this proxy,
to the extent still owned by the undersigned on the requisite record date, and
(ii) any and all other shares of capital stock of iVOW which the
undersigned may acquire after the date hereof (all such shares described in
clause (i) or (ii), being collectively referred to herein as the “Shares”).  Upon the execution hereof, all prior proxies
given by the undersigned with respect to any of the Shares are hereby revoked,
and no subsequent proxies will be given with respect to any of the Shares.

This proxy is granted in
consideration of iVOW entering into the Agreement and Plan of Reorganization (the “Merger
Agreement”) dated as of September 20, 2006, by and among iVOW,
Crdentia Corp., a Delaware corporation (“Crdentia”),
and iVOW Acquisition Corp. a Delaware corporation and wholly-owned subsidiary
of Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW continuing
as the surviving corporation of the merger and becoming a wholly-owned
subsidiary of Crdentia (the “Merger”).  This proxy is irrevocable, and is coupled
with an interest and is granted in connection with that certain iVOW Merger
Voting Agreement dated as of the date hereof, by and between iVOW and the
undersigned (the “Voting
Agreement”).  Capitalized
terms used in this proxy which are not defined herein will have the meanings
given to such terms in the Voting Agreement.

The attorneys and proxies
named above will be empowered, and may exercise this proxy, to vote the Shares
at any time until the Expiration Date at any meeting of the shareholders of
iVOW, however called, or in any action by written consent of shareholders of
iVOW:

(i)            in favor of the Merger, the
execution and delivery by iVOW of the Merger Agreement and the adoption and
approval of the terms thereof and in favor of each of the other actions and
transactions contemplated by the Merger Agreement and any action required in
furtherance hereof and thereof;

(ii)           against any action or agreement that
would result in a breach of any representation, warranty, covenant or
obligation of iVOW in the Merger Agreement or that would preclude fulfillment
of a condition precedent under the Merger Agreement to iVOW’s respective to
consummate the Merger; and

(iii)          against the following actions (other
than the Merger and the transactions contemplated by the Merger Agreement): (A)
the sale or exchange of iVOW’s

 

capital stock,
other than (x) upon exercise or conversion of iVOW’s outstanding options,
warrants or notes, or (y) to any employee, consultant or director of iVOW for
purposes of retaining their services, (B) the merger of iVOW with, or the
direct or indirect disposition of a significant amount of the assets or the
business of iVOW to, any third party, or (C) the licensing of iVOW IP Rights to
any third party other than licensing transactions which are in the ordinary
course of Vanguard’s business and not material to iVOW or its business (each of
the actions described in clauses (A), (B) and (C) being referred to herein as
an “Alternative
Transaction”); (D) any reorganization, recapitalization,
dissolution or liquidation of iVOW or any subsidiary of iVOW; (E) any material
change in the capitalization of iVOW or iVOW’s corporate structure not
contemplated by the Merger Agreement; or (F) any other action which is
intended, or could reasonably be expected to, impede, interfere with, delay,
postpone, discourage or adversely affect the Merger or any of the other
transactions contemplated by the Merger Agreement or this Agreement.

The attorneys and proxies
named above may not exercise this Proxy on any other matter except as provided
above.  The undersigned shareholder may
vote the Shares on all other matters.

This proxy will be
binding upon the heirs, successors and assigns of the undersigned (including
any transferee of any of the Shares).

[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK]

 2

 

This
proxy will terminate upon the Expiration Date.

 

	
  Dated: September 20, 2006

  
	
   

  
	
   

  
	
  iVOW SHAREHOLDER

  
	
   

  
	
  MEDCAP
  PARTNERS L.P.

  
	
   

  
	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

iVOW Common Stock:        shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase            
shares of Common Stock

	
  Address:

  
	
   

  
	
  MEDCAP
  MASTER FUND L.P.

  
	
   

  
	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

iVOW Common Stock:        shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase        
shares of Common Stock

Address:

 

 

[Signature
Page to Irrevocable Proxy]EXHIBIT 10.2

CRDENTIA MERGER VOTING AGREEMENT

This CRDENTIA MERGER  VOTING AGREEMENT (this “Agreement”)
is made and entered into as of September 20, 2006 (the “Effective
Date”), by and among Crdentia Corp., a Delaware corporation (“Crdentia”), and MedCap Partners L.P. and MedCap Master Fund
L.P. (collectively, “Shareholder”).

RECITALS

A.            This Agreement is entered into in connection with that
certain Agreement and Plan of Reorganization (the “Merger Agreement”) dated as
of September 20, 2006, by and among iVOW, Crdentia Corp., a Delaware
corporation (“Crdentia”), and iVOW
Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of
Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW
continuing as the surviving corporation of the merger and becoming a
wholly-owned subsidiary of Crdentia (the “Merger”).  Capitalized terms used in this Agreement
which are not otherwise defined herein will have the meanings given to such
terms in the Merger Agreement.

B.            As of the Effective Date of this Agreement, Shareholder
owns in the aggregate (including shares held both beneficially and of record
and other shares held either beneficially or of record) the number of shares of
Crdentia Common Stock set forth below Shareholder’s name on the signature page
of this Agreement (all such shares together with any shares of voting stock of
Crdentia that may hereafter be acquired by Shareholder, being collectively
referred to herein as the “Subject Shares”).

C.            Shareholder is entering into this Agreement as a material
inducement to, and in consideration of, iVOW’s willingness to enter into the
Merger Agreement.

AGREEMENT

The parties to this
Agreement, intending to be legally bound, agree as follows:

1.             Transfer of Subject Shares.

1.1          No Disposition or Encumbrance of
Subject Shares. 
Shareholder agrees that, prior to the Expiration Date, Shareholder will
not, directly or indirectly, sell, transfer, exchange, pledge or otherwise
dispose of, or in any other way reduce Shareholder’s risk of ownership or
investment in, or make any offer or agreement relating to any of the foregoing
with respect to, any Subject Shares, except pursuant to the Merger Agreement
and except for distributions of shares to Shareholder’s limited partners, or
sales of shares with the proceeds distributed to Shareholder’s limited
partners, in the ordinary course of Shareholder’s business consistent with the
terms of the Shareholder’s Limited Partnership Agreement made in order to
satisfy Shareholder’s obligations to its limited partners upon the redemption
of fund interests in accordance with Shareholder’s Limited Partnership
Agreement.  As used herein, the term

 

“Expiration Date” means the earliest to occur of
(i) the Effective Time of the Merger, or (ii) such time as the Merger Agreement
or this Agreement may be terminated in accordance with their respective terms.

1.2          Transfer of Voting Rights.  Shareholder agrees that,
prior to the Expiration Date, Shareholder will not deposit any of the Subject
Shares into a voting trust or grant a proxy or enter into an agreement of any
kind with respect to the voting of any of the Subject Shares, except for the
Proxy called for by Section 2.2 of this Agreement.

2.             Voting
of Subject Shares.

2.1          Voting Agreement.  Shareholder agrees that,
prior to the Expiration Date, at any meeting of the shareholders of Crdentia,
however called, and in any action taken by the written consent of shareholders
of Crdentia without a meeting to vote as set forth therein, Shareholder will
vote the Subject Shares:

(i)            in favor of the Merger, the
execution and delivery by Crdentia of the Merger Agreement and the adoption and
approval of the terms thereof and in favor of each of the other actions and
transactions contemplated by the Merger Agreement and any action required in
furtherance hereof and thereof;

(ii)           against any action or agreement that
would result in a breach of any representation, warranty, covenant or
obligation of Crdentia in the Merger Agreement or that would preclude
fulfillment of a condition precedent under the Merger Agreement to Crdentia’s
obligations to consummate the Merger; and

(iii)          against any action which is intended,
or could reasonably be expected to, impede, interfere with, delay, postpone,
discourage or adversely affect the Merger or any of the other transactions
contemplated by the Merger Agreement or this Agreement.

Prior to the Expiration
Date, Shareholder will not enter into any agreement or understanding with any
person or entity to vote or give instructions in any manner inconsistent with
this Section 2.1.

2.2          Proxy.  Contemporaneously with the
execution of this Agreement, Shareholder will deliver to Crdentia a proxy with
respect to the Subject Shares in the form attached hereto as Exhibit 1,
which proxy will be irrevocable to the fullest extent permitted by law (the “Proxy”) and will provide that
Crdentia may vote the Subject Shares in accordance with Section 2.1.

 2
 

 

3.             Representations,
Warranties and Covenants of Shareholder.  Shareholder hereby represents, warrants and
covenants as follows:

3.1          Authority, Enforceability.  Shareholder has the
capacity and the full power and authority to enter into, execute, deliver and
perform Shareholder’s obligations under this Agreement and to make the
representations, warranties and covenants contained herein, and that all
corporate or similar action required for the authorization, execution, delivery
and the performance of all obligations of Shareholder under this Agreement and
the agreements contemplated hereby have been obtained.  This Agreement has been duly executed and
delivered by Shareholder and constitutes a legal, valid and binding obligation
of Shareholder, enforceable against Shareholder in accordance with its terms.

3.2          Shares Owned.  As of the Effective Date of this Agreement,
Shareholder owns in the aggregate (including shares held both beneficially and
of record and other shares held either beneficially or of record) the number of
shares of Crdentia Common Stock and other securities of Crdentia set forth
below Shareholder’s name on the signature page of this Agreement, and does not
directly or indirectly own, either beneficially or of record, any shares of
capital stock of Crdentia, or rights to acquire any shares of capital stock of
Crdentia, or other securities of Crdentia, other than the securities set forth
below Shareholder’s name on the signature page hereof.

3.3          Further Assurances.  Shareholder agrees to execute and deliver any
additional documents reasonably necessary or desirable, in the opinion of
Crdentia, to carry out the purposes and intent of this Agreement and the Proxy.

4.             Miscellaneous.

4.1          Severability.  If any provision of this
Agreement, or the application thereof, will for any reason and to any extent be
invalid or unenforceable, the remainder of this Agreement and application of
such provision to other persons or circumstances will be interpreted so as to
reasonably effect the intent of the parties hereto.

4.2          Amendment and Waiver.  This Agreement or any provision hereof may be
amended, modified, superseded, canceled, renewed, waived or extended only by an
agreement in writing executed by Crdentia and Shareholder.  The waiver by a party of any breach hereof or
default in the performance hereof will not be deemed to constitute a waiver of
any other default or any succeeding breach or default.

4.3          Assignment.  This Agreement and all rights and obligations
hereunder are personal to Shareholder and may not be transferred or assigned by
Shareholder at any time.  Crdentia may
assign its rights, together with its obligations hereunder, to any parent,
subsidiary, affiliate or successor of Crdentia, as the case may be.  This Agreement will be binding upon, and
inure to the benefit of, the persons or entities who are permitted, by the terms
of this Agreement, to be successors, assigns and personal representatives of
the respective parties hereto.

 3
 

 

4.4          Governing
Law.  The validity,
interpretation and enforcement of this Agreement will be governed by and
construed in accordance with the internal laws of the State of Delaware, excluding
that body of laws pertaining to conflict of laws.

4.5          Costs of Enforcement.  If any party to this Agreement seeks to
enforce its rights under this Agreement by legal proceedings or otherwise, the
non-prevailing party will pay all costs and expenses incurred by the prevailing
party, including, without limitation, all reasonable attorneys’ and experts’
fees.

4.6          Counterparts.  This Agreement may be executed in
counterparts, each of which will be deemed an original but all of which, taken
together, constitute one and the same agreement.

4.7          Entire Agreement.  This Agreement and the documents referred to
herein constitute the entire agreement and understanding of the parties with
respect to the subject matter of this Agreement, and supersede all prior understandings
and agreements, whether oral or written, between or among the parties hereto
with respect to the specific subject matter hereof.

4.8          Specific Performance; Injunctive
Relief.  The
parties hereto acknowledge that Crdentia will be irreparably harmed and that
there will be no adequate remedy at law for a violation of any of the covenants
or agreements of Shareholder set forth herein. 
Therefore, it is agreed that, in addition to any other remedies that may
be available to Crdentia upon any such violation, Crdentia shall have the right
to enforce such covenants and agreements by specific performance, injunctive
relief or by any other means available to Crdentia at law or in equity.

4.9          Notices.  All notices and other communications required
or permitted under this Agreement shall be in writing and shall be either hand
delivered in person, sent by facsimile (with confirmation of receipt), sent by
certified or registered first class mail, postage pre-paid, or sent by
nationally recognized express courier service. 
Such notices and other communications will be effective upon receipt if
hand delivered or sent by facsimile (provided the sender receives confirmation
of receipt), three (3) business days after mailing if sent by mail, and one (1)
business day after dispatch if sent by express courier, to the following
addresses:

If to Crdentia:

Crdentia
Corp.

15001
LBJ Freeway, Suite 850

Dallas,
TX  75244

Attention:  Chief Executive Officer

Facsimile No.: (972) 392-2722

with a copy to:

Morrison & Foerster
LLP

12531 High Bluff Drive, Suite 100

San Diego, CA  92130

Attention: Stephen Rowles 

Facsimile No.: (858) 720-5125

 4
 

 

 

If to Shareholder:

To the address for Shareholder set forth on the signature page hereof;

or to such other
address as a party may have furnished to the other parties in writing pursuant
to this Section 4.9.

[Remainder of Page Intentionally Left Blank]

 5

 

IN WITNESS WHEREOF, the
undersigned parties have executed this Agreement as of the date first above
written.

Crdentia Corp.

	
  By:

  	
   

  	
   

  
	
   

  
	
  Name:

  	
   

  	
   

  
	
   

  
	
  Title:

  	
   

  	
   

  
					

 

 

SHAREHOLDER

MEDCAP
PARTNERS L.P.

	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

Crdentia Common Stock:    shares

Other Rights to Acquire
Crdentia Stock:   Warrants to purchase          
shares of Common Stock

Address:

MEDCAP MASTER
FUND L.P.

	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

Crdentia Common Stock:    shares

Other Rights to Acquire
Crdentia Stock:   Warrants to purchase        shares
of Common Stock

Address:

 

 

 

 

[Signature Page to Crdentia Voting Agreement]

 

EXHIBIT 1
TO IVOW MERGER VOTING AGREEMENT

IRREVOCABLE PROXY

The undersigned
shareholders of Crdentia Corp., a Delaware corporation (“Crdentia”),
hereby irrevocably (to the fullest extent permitted by law) appoint and
constitute James D. Durham of Crdentia the attorney and proxy of the
undersigned, with full power of substitution and resubstitution, to the extent
described below and, with respect to such matters, to the fullest extent of the
undersigned’s rights with respect to (i) the shares of capital stock of
Crdentia owned by the undersigned as of the date of this proxy, which shares
are specified on the final page of this proxy, to the extent still owned by the
undersigned on the requisite record date, and (ii) any and all other
shares of capital stock of Crdentia which the undersigned may acquire after the
date hereof (all such shares described in clause (i) or (ii), being
collectively referred to herein as the “Shares”).  Upon the execution hereof, all prior proxies
given by the undersigned with respect to any of the Shares are hereby revoked,
and no subsequent proxies will be given with respect to any of the Shares.

This proxy is granted in
consideration of Crdentia entering into the Agreement and Plan of
Reorganization (the “Merger Agreement”) dated as of
September 20, 2006, by and among iVOW, Inc., a Delaware corporation (“iVOW”), Crdentia, and iVOW
Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of
Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW continuing
as the surviving corporation of the merger and becoming a wholly-owned
subsidiary of Crdentia (the “Merger”).  This proxy is irrevocable, and is coupled
with an interest and is granted in connection with that certain Crdentia Merger
Voting Agreement dated as of the date hereof, by and between Crdentia and the
undersigned (the “Voting
Agreement”).  Capitalized
terms used in this proxy which are not defined herein will have the meanings
given to such terms in the Voting Agreement.

The attorney and proxy
named above will be empowered, and may exercise this proxy, to vote the Shares
at any time until the Expiration Date at any meeting of the shareholders of
Crdentia, however called, or in any action by written consent of shareholders
of Crdentia:

(i)            in favor of the Merger, the
execution and delivery by Crdentia of the Merger Agreement and the adoption and
approval of the terms thereof and in favor of each of the other actions and
transactions contemplated by the Merger Agreement and any action required in
furtherance hereof and thereof;

(ii)           against any action or agreement that
would result in a breach of any representation, warranty, covenant or
obligation of Crdentia in the Merger Agreement or that would preclude
fulfillment of a condition precedent under the Merger Agreement to Crdentia’s
respective to consummate the Merger; and

(iii)          against any other action which is
intended, or could reasonably be expected to, impede, interfere with, delay,
postpone, discourage or adversely affect the Merger or any of the other
transactions contemplated by the Merger Agreement or this Agreement.

The attorneys and proxies
named above may not exercise this Proxy on any other matter except as provided
above.  The undersigned shareholder may
vote the Shares on all other matters.

This proxy will be
binding upon the heirs, successors and assigns of the undersigned (including
any transferee of any of the Shares).

[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK]

 2

This
proxy will terminate upon the Expiration Date.

 

Dated:  September
20, 2006

CRDENTIA
SHAREHOLDER

MEDCAP
PARTNERS L.P.

	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

Crdentia Common Stock:    shares

Other Rights to Acquire
Crdentia Stock:   Warrants to purchase               
shares of Common Stock

Address:

MEDCAP
MASTER FUND L.P.

	
  By: 

  	
   

  	
   

  
	
  Its: 

  	
   

  	
   

  

 

Crdentia Common Stock:    shares

Other Rights to Acquire
Crdentia Stock:   Warrants to purchase           shares
of Common Stock

Address:

 

 

 

[Signature
Page to Irrevocable Proxy]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]